anonymous
Guest
anonymous
Guest
It's not about dosing it's about without APAP and ADT
A patent is based off the technology behind the delivery mechanism- unless it is a new molecule. Hydrocodone is not a new molecule. Therefore, the uniqueness of the delivery mechanism is what earns the patent. The two company's drugs are different methods of delivery which would warrant the differences in the studies.
Based on your theory- we should only be driving one brand of car.